- Titre
- Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates
- Créateurs - sans rôle
- Valérie Cesson - Department of Biochemistry, University of Lausanne, Epalinges, SwitzerlandKathrin Stirnemann - Department of Biochemistry, University of Lausanne, Epalinges, SwitzerlandBruno Robert - Institut National de la Sante et de la Recherche Medicale, EMI 0227, Centre de Recherche en Cancérologie de Montpellier, FranceImmanuel Luescher - Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, SwitzerlandThomas Filleron - CRLC Val dAurelle-Paul Lamarque, FranceGiampietro Corradin - University of LausanneJean-Pierre Mach - Department of Biochemistry, University of Lausanne, Epalinges, SwitzerlandAlena Donda - Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
- Détails de publication
- Clinical cancer research, Vol.12(24), pp.7422-7430
- Éditeur
- American Association for Cancer Research
- Nombre de pages
- 9
- Identifiants
- 99162554009311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates
Clinical cancer research, Vol.12(24), pp.7422-7430
15/12/2006
PMID: 17189415
Indicateurs
1 Consultations de la notice